| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.9 |